{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:09:03Z","timestamp":1789088943814,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["YCBZ2026144"],"award-info":[{"award-number":["YCBZ2026144"]}]},{"name":"he Key Research and Development Program Project of Guangxi Zhuang Autonomous Region","award":["GuikeAB23026020"],"award-info":[{"award-number":["GuikeAB23026020"]}]},{"name":"the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2025GXNSFDA069051"],"award-info":[{"award-number":["2025GXNSFDA069051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00875-4","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:07:08Z","timestamp":1782407228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive multi-omics analysis reveals a fatty acid metabolism gene signature for prognostic assessment and immunotherapy in nasopharyngeal carcinoma, and identifies ABCC1 as a potential novel therapeutic target"],"prefix":"10.1186","volume":"21","author":[{"given":"Yang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"3","key":"875_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"2","key":"875_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","volume":"23","author":"AD Colevas","year":"2025","unstructured":"Colevas AD, Cmelak AJ, Pfister DG, Spencer S, Adkins D, Birkeland AC, Brizel DM, Busse PM, Caudell JJ, Durm G, et al. NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Cancer Network: JNCCN. 2025;23(2):2\u201311.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"9","key":"875_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11864-023-01101-3","volume":"24","author":"JJ Juarez-Vignon Whaley","year":"2023","unstructured":"Juarez-Vignon Whaley JJ, Afkhami M, Onyshchenko M, Massarelli E, Sampath S, Amini A, Bell D, Villaflor VM. Recurrent\/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading? Curr Treat Options Oncol. 2023;24(9):1138\u201366.","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"875_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41698-024-00601-1","volume":"8","author":"X Liu","year":"2024","unstructured":"Liu X, Shen H, Zhang L, Huang W, Zhang S, Zhang B. Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma. NPJ precision Oncol. 2024;8(1):101.","journal-title":"NPJ precision Oncol"},{"key":"875_CR5","doi-asserted-by":"publisher","first-page":"101547","DOI":"10.1016\/j.lanwpc.2025.101547","volume":"57","author":"X Liu","year":"2025","unstructured":"Liu X, Ma J. Immunotherapy in nasopharyngeal carcinoma: current status and unanswered questions. Lancet Reg health Western Pac. 2025;57:101547.","journal-title":"Lancet Reg health Western Pac"},{"key":"875_CR6","doi-asserted-by":"publisher","first-page":"175883592210962","DOI":"10.1177\/17588359221096214","volume":"14","author":"JY Xu","year":"2022","unstructured":"Xu JY, Wei XL, Wang YQ, Wang FH. Current status and advances of immunotherapy in nasopharyngeal carcinoma. Therapeutic Adv Med Oncol. 2022;14:17588359221096214.","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"5","key":"875_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1200\/JCO.22.02328","volume":"41","author":"E Yilmaz","year":"2023","unstructured":"Yilmaz E, Ismaila N, Bauman JE, Dabney R, Gan G, Jordan R, Kaufman M, Kirtane K, McBride SM, Old MO, et al. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. J Clin oncology: official J Am Soc Clin Oncol. 2023;41(5):1132\u201346.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"11","key":"875_CR8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"875_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metabol. 2022;34(3):355\u201377.","journal-title":"Cell Metabol"},{"key":"875_CR10","doi-asserted-by":"crossref","unstructured":"Matsushita Y, Nakagawa H, Koike K. Lipid metabolism in oncology: why it matters, how to research, and how to treat. Cancers 2021;13(3).","DOI":"10.3390\/cancers13030474"},{"key":"875_CR11","doi-asserted-by":"publisher","first-page":"919496","DOI":"10.3389\/fmicb.2022.919496","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Liang J, Hu W, Liang Y, Xiao X, Zhao W, Zhong X, Yang Y, Pan X, Zhou X, et al. Integration Profiling Between Plasma Lipidomics, Epstein-Barr Virus and Clinical Phenomes in Nasopharyngeal Carcinoma Patients. Front Microbiol. 2022;13:919496.","journal-title":"Front Microbiol"},{"key":"875_CR12","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhou Y, Ren R, Chen Y, Lei J, Li Y. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer. 2024;12(7).","DOI":"10.1136\/jitc-2024-008811"},{"issue":"1","key":"875_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","volume":"14","author":"W Yu","year":"2021","unstructured":"Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol. 2021;14(1):187.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"875_CR14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami JK, Morrow D, Bayley NA, Fernandez EG, Salinas JJ, Tse C, Zhu H, Su B, Plawat R, Jones A, et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell. 2023;41(6):1048\u2013e10601049.","journal-title":"Cancer Cell"},{"key":"875_CR15","doi-asserted-by":"publisher","first-page":"155905","DOI":"10.1016\/j.metabol.2024.155905","volume":"155","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu X, Yang D, Li L, Li S, Lu S, Li N. Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression. Metab Clin Exp. 2024;155:155905.","journal-title":"Metab Clin Exp"},{"issue":"4","key":"875_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365\u2013e378366.","journal-title":"Cancer Cell"},{"issue":"6","key":"875_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-21-3114","volume":"28","author":"PL Triozzi","year":"2022","unstructured":"Triozzi PL, Stirling ER, Song Q, Westwood B, Kooshki M, Forbes ME, Holbrook BC, Cook KL, Alexander-Miller MA, Miller LD, et al. Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients\u2019 Response to Anti-PD-1 Immune Checkpoint Blockade. Clin cancer research: official J Am Association Cancer Res. 2022;28(6):1192\u2013202.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"2","key":"875_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metabol. 2013;18(2):153\u201361.","journal-title":"Cell Metabol"},{"issue":"10","key":"875_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"7693","key":"875_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"1","key":"875_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"10","key":"875_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"875_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","volume":"12","author":"L Gong","year":"2021","unstructured":"Gong L, Kwong DL, Dai W, Wu P, Li S, Yan Q, Zhang Y, Zhang B, Fang X, Liu L, et al. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma. Nat Commun. 2021;12(1):1540.","journal-title":"Nat Commun"},{"issue":"11","key":"875_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","volume":"23","author":"A Sajid","year":"2023","unstructured":"Sajid A, Rahman H, Ambudkar SV. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nat Rev Cancer. 2023;23(11):762\u201379.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"875_CR25","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1038\/s41467-023-41229-2","volume":"14","author":"J Ebner","year":"2023","unstructured":"Ebner J, Schmoellerl J, Piontek M, Manhart G, Troester S, Carter BZ, Neubauer H, Moriggl R, Szak\u00e1cs G, Zuber J, et al. ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia. Nat Commun. 2023;14(1):5709.","journal-title":"Nat Commun"},{"issue":"6","key":"875_CR26","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C, He Z, Wang R, Xu Y, Jiang G, Wan Y, Mei J, Mao W. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13(6):1774\u2013808.","journal-title":"Theranostics"},{"key":"875_CR27","doi-asserted-by":"publisher","first-page":"105102","DOI":"10.1016\/j.ebiom.2024.105102","volume":"103","author":"M Hashimoto","year":"2024","unstructured":"Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, et al. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. EBioMedicine. 2024;103:105102.","journal-title":"EBioMedicine"},{"issue":"7","key":"875_CR28","doi-asserted-by":"publisher","first-page":"110077","DOI":"10.1016\/j.isci.2024.110077","volume":"27","author":"H Fei","year":"2024","unstructured":"Fei H, Chen T, Jiang H. Autocrine and paracrine effects of MDK promote lymph node metastasis of cervical squamous cell carcinoma. iScience. 2024;27(7):110077.","journal-title":"iScience"},{"issue":"1","key":"875_CR29","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1038\/s41467-024-52615-9","volume":"15","author":"S Hu","year":"2024","unstructured":"Hu S, Hu C, Xu J, Yu P, Yuan L, Li Z, Liang H, Zhang Y, Chen J, Wei Q, et al. The estrogen response in fibroblasts promotes ovarian metastases of gastric cancer. Nat Commun. 2024;15(1):8447.","journal-title":"Nat Commun"},{"key":"875_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","volume":"65","author":"SK Daniel","year":"2020","unstructured":"Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Sem Cancer Biol. 2020;65:176\u201388.","journal-title":"Sem Cancer Biol"},{"issue":"18","key":"875_CR31","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, Sirven P, Baudrin LG, Baulande S, Nicolas A, et al. Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer. Cancer Res. 2022;82(18):3291\u2013306.","journal-title":"Cancer Res"},{"issue":"5","key":"875_CR32","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.gendis.2021.07.002","volume":"9","author":"L Yang","year":"2022","unstructured":"Yang L, Liu G, Li Y, Pan Y. The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications. Genes Dis. 2022;9(5):1208\u201319.","journal-title":"Genes Dis"},{"issue":"1","key":"875_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01928-2","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H, Tang L, Li Y, Xie W, Zhang L, Tang H, Xiao T, Yang H, Gu W, Wang H, et al. Nasopharyngeal carcinoma: current views on the tumor microenvironment\u2019s impact on drug resistance and clinical outcomes. Mol Cancer. 2024;23(1):20.","journal-title":"Mol Cancer"},{"issue":"3","key":"875_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2024.01.005","volume":"36","author":"C Hu","year":"2024","unstructured":"Hu C, Qiao W, Li X, Ning ZK, Liu J, Dalangood S, Li H, Yu X, Zong Z, Wen Z, et al. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8(+)T cells. Cell Metabol. 2024;36(3):630\u2013e647638.","journal-title":"Cell Metabol"},{"issue":"1","key":"875_CR35","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41467-023-37614-6","volume":"14","author":"L Gong","year":"2023","unstructured":"Gong L, Luo J, Zhang Y, Yang Y, Li S, Fang X, Zhang B, Huang J, Chow LK, Chung D, et al. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. Nat Commun. 2023;14(1):1912.","journal-title":"Nat Commun"},{"key":"875_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-immunol-032414-112008","volume":"34","author":"L Mori","year":"2016","unstructured":"Mori L, Lepore M, De Libero G. The Immunology of CD1- and MR1-Restricted T Cells. Annu Rev Immunol. 2016;34:479\u2013510.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"875_CR37","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s43018-024-00830-0","volume":"5","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wang Y, Dou Z, Delfanti G, Tsahouridis O, Pellegry CM, Zingarelli M, Atassi G, Woodcock MG, Casorati G, et al. CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms. Nat cancer. 2024;5(11):1607\u201321.","journal-title":"Nat cancer"},{"key":"875_CR38","doi-asserted-by":"crossref","unstructured":"R\u00f6der A, H\u00fcsken S, Hutter MC, Rettie AE, Hanenberg H, Wiek C, Girhard M. Spotlight on CYP4B1. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032038"},{"issue":"2","key":"875_CR39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/acs.jproteome.3c00700","volume":"23","author":"D Qi","year":"2024","unstructured":"Qi D, Liu C, Zhang Z, Liu X, Kang P. Construction of a Lung Adenocarcinoma Prognostic Model Utilizing Serine and Glycine Metabolism-Related Genes. J Proteome Res. 2024;23(2):797\u2013808.","journal-title":"J Proteome Res"},{"key":"875_CR40","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang T, Du H, Yang M, Xie G, Liu T, Deng S, Yuan W, He S, Wu D et al. Dipeptidase\u20132 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin. Oncol Rep. 2023;50(2).","DOI":"10.3892\/or.2023.8598"},{"issue":"1","key":"875_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"HR Jin","year":"2023","unstructured":"Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, Yang JL. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16(1):103.","journal-title":"J Hematol Oncol"},{"key":"875_CR42","doi-asserted-by":"publisher","first-page":"216043","DOI":"10.1016\/j.canlet.2022.216043","volume":"559","author":"Q Wang","year":"2023","unstructured":"Wang Q, Qin Y, Li B. CD8(+) T cell exhaustion and cancer immunotherapy. Cancer Lett. 2023;559:216043.","journal-title":"Cancer Lett"},{"issue":"2","key":"875_CR43","doi-asserted-by":"publisher","first-page":"188631","DOI":"10.1016\/j.bbcan.2021.188631","volume":"1876","author":"S Pathania","year":"2021","unstructured":"Pathania S, Pentik\u00e4inen OT, Singh PK. A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors. Biochim et Biophys acta Reviews cancer. 2021;1876(2):188631.","journal-title":"Biochim et Biophys acta Reviews cancer"},{"issue":"1","key":"875_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-023-01770-6","volume":"22","author":"B Li","year":"2023","unstructured":"Li B, Chen H, Yang S, Chen F, Xu L, Li Y, Li M, Zhu C, Shao F, Zhang X, et al. Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers. Mol Cancer. 2023;22(1):71.","journal-title":"Mol Cancer"},{"issue":"36","key":"875_CR45","first-page":"e2310304","volume":"11","author":"X Luo","year":"2024","unstructured":"Luo X, Huang W, Li S, Sun M, Hu D, Jiang J, Zhang Z, Wang Y, Wang Y, Zhang J, et al. SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression. Advanced science (Weinheim. Baden-Wurttemberg Germany). 2024;11(36):e2310304.","journal-title":"Baden-Wurttemberg Germany)"},{"issue":"Pt 3","key":"875_CR46","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.semcancer.2021.12.011","volume":"86","author":"S Raza","year":"2022","unstructured":"Raza S, Rajak S, Tewari A, Gupta P, Chattopadhyay N, Sinha RA, Chakravarti B. Multifaceted role of chemokines in solid tumors: From biology to therapy. Sem Cancer Biol. 2022;86(Pt 3):1105\u201321.","journal-title":"Sem Cancer Biol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00875-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00875-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00875-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:27:26Z","timestamp":1789086446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00875-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00875-4","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures involving animals were approved by the Animal Ethics Committee of Guangxi Medical University (Approval No. 202506003) and were performed in compliance with the institutional Guidelines for Animal Care and Use. The study protocol involving human participants or specimens was reviewed and approved by the Ethics Committee of Guangxi Medical University Cancer Hospital (Approval No. KY-2022-310), and was conducted in accordance with the principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"If any of the sections are not relevant to your manuscript, please include the heading and write \u2018Not applicable\u2019 for that section.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"173"}}